Scarica l'app Stockscreener
0.2867
5.32%
-0.0161
Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie
Xtant Medical Holdings (XTNT) Slips to $0.32 as Shares Test Lower SupportBreadth Thrust - https://www.dars.gov.et/
Xtant Medical Holdings (XTNT) Slips to $0.32 as Shares Test Lower SupportPut Dominated - https://www.dars.gov.et/
Xtant Medical stock sits 66.32 percent below its 52-week high - AD HOC NEWS
Xtant: A Smaller Top Line, a Bigger Cash Question - Orthopedics This Week
Xtant: A Smaller Top Line, a Bigger Cash Question - Orthopedics This Week
Xtant Medical stock reports a second quarter revenue miss - AD HOC NEWS
Xtant Medical stock draws a USD 1.00 target from Lucid Capital - AD HOC NEWS
Xtant Medical Holdings, Inc. (XMS.SG) Analyst insights, Price targets and RecommendationsYahoo Finance - Yahoo Finance Singapore
Xtant Medical stock trades quietly as investors weigh recent financial trends - AD HOC NEWS
Xtant Medical Holdings stock holds steady as investors eye latest results - AD HOC NEWS
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Eastern Progress
Xtant Medical Holdings Inc. (XTNT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
XTNT stock focus shifts to latest medical device results and valuation - ad-hoc-news.de
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com Canada
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com South Africa
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com Nigeria
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com UK
Lucid Capital initiates Xtant Medical stock with buy rating - Investing.com
Xtant Medical Holdings Inc. (XTNT) Peer Comparison – Compare with Others - Value Research
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Xtant Medical Holdings Inc. (XTNT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market - TechStock²
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - Sahm
XTNT SEC Filings, Jul-Aug 2025Xtant Medical Holdings, Inc. Filing Archive - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Nigeria
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Canada
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - PR Newswire
Xtant Medical partners with BioHorizons for dental distribution - Investing.com
BioHorizons will exclusively sell Xtant’s growth factor in the U.S. and Canada - Stock Titan
Xtant Medical Earnings Call: Growth Bets Amid Setbacks - TipRanks
ETFs Investing in Xtant Medical Holdings, Inc. Stocks - TradingView
Xtant (XTNT) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Move - vinanet.vn
Xtant Medical (XTNT) insider reports new stock transaction - Stock Titan
Xtant Medical (XTNT) insider updates SEC on stock transaction - Stock Titan
Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT) - theglobeandmail.com
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com Nigeria
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
Xtant Medical (XTNT) revenue drops 35% and turns to loss on divestitures, Dilon charge - Stock Titan
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract - TradingKey
Xtant Medical Q2 Revenue Falls To $23.0 Million - Quiver Quantitative
XTNT: Q2 2026 saw revenue drop, margin compression, and a net loss, prompting lower full-year guidance - tradingview.com
9.55%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):